Search

Your search keyword '"Gómez-Vera, J"' showing total 86 results

Search Constraints

Start Over You searched for: Author "Gómez-Vera, J" Remove constraint Author: "Gómez-Vera, J"
86 results on '"Gómez-Vera, J"'

Search Results

1. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

2. Recommendations for the prevention and diagnosis of asthma in children: Evidence from international guidelines adapted for Mexico

5. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

6. Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

7. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

8. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

9. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

10. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

11. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

12. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

13. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

14. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

15. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

16. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

17. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

18. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - Reference Site Twinning (EIP on AHA)

20. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

21. Geolocation with respect to personal privacy for the Allergy Diary app - A MASK study

22. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

23. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

24. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly ( MACVIA ‐ ARIA ) ‐ EIP on AHA Twinning Reference Site ( GARD research demonstration project)

25. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

26. Necropulpectomía : tratamiento conservador en necrosis pulpar de un canino en un pastor alemán

28. Guía mexicana del asma: GUIMA 2017,Mexican Asthma Guidelines: GUIMA 2017

29. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

30. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.

31. [Executive Summary of ARIA 2019: Integrated care pathways for allergic rhinitis in Argentina, Spain and Mexico].

32. [MASK (Mobile Airways Sentinel Network), a mobile App with ARIA's comprehensive solution in Spanish-speaking countries].

33. [GUIMIT 2019, Mexican Guideline on Immunotherapy. Guideline on the diagnosis of IgE-mediated allergic disease and immunotherapy following the ADAPTE approach].

34. Pediatric asthma treatment: What to do when international guideline recommendations do not agree.

35. [Mexican consensus on the diagnosis and treatment of atopic dermatitis in adolescents and adults].

36. [Mexican Asthma Guidelines: GUIMA 2017].

37. Omalizumab in the treatment of antihistamine-resistant chronic urticaria in adults.

38. [Mexican guidelines on the diagnosis and treatment of urticaria].

39. [Risk factors associated with the development of atopic march. Case-control study].

40. NFE2L2 gene variants and susceptibility to childhood-onset asthma.

41. Omalizumab (an anti-IgE antibody) in the treatment of severe atopic eczema.

42. Transfer factor and allergy.

43. [IgE deficiency: a forgotten disease?].

44. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population.

45. [Association between chronic urticaria and Helicobacter pylori].

46. [Hereditary angioedema. A report of a case and literature review].

47. [Safety and efficacy of specific sublingual immunotherapy in patients with asthma and allergy to Dermatophagoides pteronyssinus].

48. [Transfer factor as specific immunomodulator in the treatment of moderate-severe atopic dermatitis].

49. Discontinuation of antiretroviral therapy in patients with chronic HIV infection: clinical, virologic, and immunologic consequences.

50. [Pulse oxymetry in the diagnosis of asthma in children].

Catalog

Books, media, physical & digital resources